Growing up in a small town in Louisiana with a passion for what made some stocks great and others not so great, Luke Downey performed his first investing exercise as a teenager. With the desire for financial knowledge, he moved to New York City directly after graduation. After a brief stint at a day-trading firm, he landed a job on an institutional trading desk handling large orders of stock and derivatives. The rest was history.
Luke served as Head of ETF Sales at Cantor Fitzgerald. While in this seat, he began to notice the importance that institutional trading activity had on the movements and direction of stocks. He spent years observing these activities and in his free time, with a partner, began designing quantitative models to look for unusual trading activity. He later moved to Jefferies, LLC as an SVP of Derivatives. There he published stock research based around the unusual activity signals he was developing. He later left Wall Street to work on this research full time at MAPsignals.com.
As a former institutional sales trader on Wall Street, Luke understands the importance that large institutional trades play in uncovering the leading stocks of tomorrow. The best stocks, the outliers, will always be found by the brightest minds on Wall Street.
Read more: Lucas Downey Bio | Investopedia https://www.investopedia.com/contributors/82553/#ixzz5RONPftj9
Follow him on LinkedIn and Twitter
Written by Lucas Downey5 Tips to Keep in Mind if You Want to Begin Options Trading
Learning just a few basic characteristics about options make them very useful and easy to understand Read More >
Arista Networks Stock Shows Unusual Bullish Trading Activity
Solid earnings and sales growth along with multiple accumulation signals suggest continued upside potential for Arista Networks ... Read More >
Baidu Shares Have Been in Demand
After a recent breakout to new 52-week highs, institutional accumulation signals suggest additional upside potential for ... Read More >
AbbVie Stock Is Signaling That a Move to the Upside Could Be Near
A recent pullback, dividend growth and institutional accumulation could make AbbVie shares an attractive long-term investment... Read More >